Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

De novo SMARCA2 variants clustered outside the helicase domain cause a new recognizable syndrome with intellectual disability and blepharophimosis distinct from Nicolaides-Baraitser syndrome

G. Cappuccio, C. Sayou, PL. Tanno, E. Tisserant, AL. Bruel, SE. Kennani, J. Sá, KJ. Low, C. Dias, M. Havlovicová, M. Hančárová, EE. Eichler, F. Devillard, S. Moutton, J. Van-Gils, C. Dubourg, S. Odent, B. Gerard, A. Piton, T. Yamamoto, N....

. 2020 ; 22 (11) : 1838-1850. [pub] 20200722

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21019890

Grantová podpora
GSP15001 Telethon - Italy
209568/Z/17/Z Wellcome Trust - United Kingdom
Department of Health - United Kingdom
NV17-29423A MZ0 CEP - Centrální evidence projektů

PURPOSE: Nontruncating variants in SMARCA2, encoding a catalytic subunit of SWI/SNF chromatin remodeling complex, cause Nicolaides-Baraitser syndrome (NCBRS), a condition with intellectual disability and multiple congenital anomalies. Other disorders due to SMARCA2 are unknown. METHODS: By next-generation sequencing, we identified candidate variants in SMARCA2 in 20 individuals from 18 families with a syndromic neurodevelopmental disorder not consistent with NCBRS. To stratify variant interpretation, we functionally analyzed SMARCA2 variants in yeasts and performed transcriptomic and genome methylation analyses on blood leukocytes. RESULTS: Of 20 individuals, 14 showed a recognizable phenotype with recurrent features including epicanthal folds, blepharophimosis, and downturned nasal tip along with variable degree of intellectual disability (or blepharophimosis intellectual disability syndrome [BIS]). In contrast to most NCBRS variants, all SMARCA2 variants associated with BIS are localized outside the helicase domains. Yeast phenotype assays differentiated NCBRS from non-NCBRS SMARCA2 variants. Transcriptomic and DNA methylation signatures differentiated NCBRS from BIS and those with nonspecific phenotype. In the remaining six individuals with nonspecific dysmorphic features, clinical and molecular data did not permit variant reclassification. CONCLUSION: We identified a novel recognizable syndrome named BIS associated with clustered de novo SMARCA2 variants outside the helicase domains, phenotypically and molecularly distinct from NCBRS.

Birmingham Women's NHS Foundation Trust Birmingham UK

Cambridge University Hospitals NHS Foundation Trust Cambridge Biomedical Campus Cambridge UK

Centre de génétique humaine Université de Franche Comté Besançon France

Centre de Référence Déficiences Intellectuelles de Causes Rares CHU Dijon Dijon France

Clinical Genetics Great Ormond Street Hospital for Children NHS Foundation Trust London UK

CPDPN Pôle mère enfant Maison de Santé Protestante Bordeaux Bagatelle Talence France

Dell Children's Medical Group Austin TX USA

Department of Biology and Medical Genetics Charles University Prague 2nd Faculty of Medicine and University Hospital Motol Prague Czech Republic

Department of Genetics and Metabolism Children's National Medical Center Washington DC USA

Department of Genetics and Reproduction Centre Hospitalo Universitaire Grenoble Alpes Grenoble France

Department of Genetics Robert Debré Hospital AP HP Paris France

Department of Genome Sciences University of Washington School of Medicine Seattle WA USA

Department of Medical and Molecular Genetics King's College London UK

Department of Medical Genetics Osaka Women's and Children's Hospital Osaka Japan

Department of Medical Genetics Poitiers University Hospital Poitiers France

Department of Pathology and Laboratory Medicine Western University London Canada

Department of Pediatrics and Translational Genetics Academic Medical Center University of Amsterdam Amsterdam The Netherlands

Department of Pediatrics The University of Texas at Austin Dell Medical School Austin TX USA

Department of Precision Medicine University of Campania Luigi Vanvitelli Naples Italy

Department of Translational Medicine Federico 2 University Naples Italy

Howard Hughes Medical Institute University of Washington Seattle WA USA

Inserm U1209 CNRS UMR 5309 Univ Grenoble Alpes Institute for Advanced Biosciences Grenoble France

Inserm UMR 1231 GAD Genetics of Developmental disorders Université de Bourgogne Franche Comté FHU TRANSLAD Dijon France

Institut de Génétique et de Biologie Moléculaire et Cellulaire Illkirch France

Institute of Medical Genetics Tokyo Women's Medical University Tokyo Japan

Manchester Centre for Genomic Medicine Manchester UK

Medical Genetics Unit Hospital Pediátrico Centro Hospitalar e Universitário de Coimbra Coimbra Portugal

Molecular Genetics Laboratory Victoria Hospital London Health Sciences Centre London ON Canada

Oxford Centre for Genomic Medicine Oxford University Hospitals NHS Foundation Trust Oxford UK

Reference Center for Developmental Anomalies Department of Medical Genetics Bordeaux University Hospital Bordeaux France

Service de Génétique clinique CHU de Rennes Univ Rennes Institut de Génétique et Développement de Rennes UMR 6290 Rennes France

Service de Génétique Moléculaire et Génomique BMT HC « Jean Dausset » Rennes France

Telethon Institute of Genetics and Medicine Pozzuoli Italy

The Francis Crick Institute London UK

Tokyo Women's Medical University Institute of Integrated Medical Sciences Tokyo Japan

UF Innovation en diagnostic génomique des maladies rares CHU Dijon Dijon France

University Clinic of Genetics Faculty of Medicine Universidade de Coimbra Coimbra Portugal

University Hospitals Bristol NHS Foundation Trust University of Bristol Bristol UK

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019890
003      
CZ-PrNML
005      
20210830101507.0
007      
ta
008      
210728s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41436-020-0898-y $2 doi
035    __
$a (PubMed)32694869
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Cappuccio, Gerarda $u Department of Translational Medicine, Federico II University, Naples, Italy $u Telethon Institute of Genetics and Medicine, Pozzuoli, Italy
245    10
$a De novo SMARCA2 variants clustered outside the helicase domain cause a new recognizable syndrome with intellectual disability and blepharophimosis distinct from Nicolaides-Baraitser syndrome / $c G. Cappuccio, C. Sayou, PL. Tanno, E. Tisserant, AL. Bruel, SE. Kennani, J. Sá, KJ. Low, C. Dias, M. Havlovicová, M. Hančárová, EE. Eichler, F. Devillard, S. Moutton, J. Van-Gils, C. Dubourg, S. Odent, B. Gerard, A. Piton, T. Yamamoto, N. Okamoto, H. Firth, K. Metcalfe, A. Moh, KA. Chapman, E. Aref-Eshghi, J. Kerkhof, A. Torella, V. Nigro, L. Perrin, J. Piard, G. Le Guyader, T. Jouan, C. Thauvin-Robinet, Y. Duffourd, JK. George-Abraham, CA. Buchanan, D. Williams, U. Kini, K. Wilson, Telethon Undiagnosed Diseases Program, SB. Sousa, RCM. Hennekam, B. Sadikovic, J. Thevenon, J. Govin, A. Vitobello, N. Brunetti-Pierri
520    9_
$a PURPOSE: Nontruncating variants in SMARCA2, encoding a catalytic subunit of SWI/SNF chromatin remodeling complex, cause Nicolaides-Baraitser syndrome (NCBRS), a condition with intellectual disability and multiple congenital anomalies. Other disorders due to SMARCA2 are unknown. METHODS: By next-generation sequencing, we identified candidate variants in SMARCA2 in 20 individuals from 18 families with a syndromic neurodevelopmental disorder not consistent with NCBRS. To stratify variant interpretation, we functionally analyzed SMARCA2 variants in yeasts and performed transcriptomic and genome methylation analyses on blood leukocytes. RESULTS: Of 20 individuals, 14 showed a recognizable phenotype with recurrent features including epicanthal folds, blepharophimosis, and downturned nasal tip along with variable degree of intellectual disability (or blepharophimosis intellectual disability syndrome [BIS]). In contrast to most NCBRS variants, all SMARCA2 variants associated with BIS are localized outside the helicase domains. Yeast phenotype assays differentiated NCBRS from non-NCBRS SMARCA2 variants. Transcriptomic and DNA methylation signatures differentiated NCBRS from BIS and those with nonspecific phenotype. In the remaining six individuals with nonspecific dysmorphic features, clinical and molecular data did not permit variant reclassification. CONCLUSION: We identified a novel recognizable syndrome named BIS associated with clustered de novo SMARCA2 variants outside the helicase domains, phenotypically and molecularly distinct from NCBRS.
650    12
$a blefarofimóza $7 D016569
650    _2
$a faciální stigmatizace $7 D019066
650    _2
$a vrozené deformity nohy (od hlezna dolů) $7 D005532
650    _2
$a lidé $7 D006801
650    12
$a hypotrichóza $7 D007039
650    12
$a mentální retardace $x genetika $7 D008607
650    _2
$a fenotyp $7 D010641
650    _2
$a transkripční faktory $x genetika $7 D014157
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Sayou, Camille $u Inserm U1209, CNRS UMR 5309, Univ. Grenoble Alpes, Institute for Advanced Biosciences, Grenoble, France
700    1_
$a Tanno, Pauline Le $u Department of Genetics and Reproduction, Centre Hospitalo-Universitaire Grenoble-Alpes, Grenoble, France
700    1_
$a Tisserant, Emilie $u Inserm UMR 1231 GAD, Genetics of Developmental disorders, Université de Bourgogne-Franche Comté, FHU TRANSLAD, Dijon, France
700    1_
$a Bruel, Ange-Line $u Inserm UMR 1231 GAD, Genetics of Developmental disorders, Université de Bourgogne-Franche Comté, FHU TRANSLAD, Dijon, France
700    1_
$a Kennani, Sara El $u Inserm U1209, CNRS UMR 5309, Univ. Grenoble Alpes, Institute for Advanced Biosciences, Grenoble, France
700    1_
$a Sá, Joaquim $u Medical Genetics Unit, Hospital Pediátrico, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
700    1_
$a Low, Karen J $u University Hospitals Bristol NHS Foundation Trust, University of Bristol, Bristol, UK
700    1_
$a Dias, Cristina $u Department of Medical and Molecular Genetics, King's College, London, UK $u The Francis Crick Institute, London, UK $u Clinical Genetics, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK
700    1_
$a Havlovicová, Markéta $u Department of Biology and Medical Genetics, Charles University Prague 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic
700    1_
$a Hančárová, Miroslava $u Department of Biology and Medical Genetics, Charles University Prague 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic
700    1_
$a Eichler, Evan E $u Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA $u Howard Hughes Medical Institute, University of Washington, Seattle, WA, USA
700    1_
$a Devillard, Françoise $u Department of Genetics and Reproduction, Centre Hospitalo-Universitaire Grenoble-Alpes, Grenoble, France
700    1_
$a Moutton, Sébastien $u CPDPN, Pôle mère enfant, Maison de Santé Protestante Bordeaux Bagatelle, Talence, France
700    1_
$a Van-Gils, Julien $u Reference Center for Developmental Anomalies, Department of Medical Genetics, Bordeaux University Hospital, Bordeaux, France
700    1_
$a Dubourg, Christèle $u Service de Génétique Moléculaire et Génomique, BMT-HC « Jean Dausset », Rennes, France
700    1_
$a Odent, Sylvie $u Service de Génétique clinique, CHU de Rennes, Univ. Rennes, Institut de Génétique et Développement de Rennes (IGDR) UMR 6290, Rennes, France
700    1_
$a Gerard, Bénédicte $u Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France
700    1_
$a Piton, Amélie $u Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France
700    1_
$a Yamamoto, Toshiyuki $u Institute of Medical Genetics, Tokyo Women's Medical University, Tokyo, Japan $u Tokyo Women's Medical University Institute of Integrated Medical Sciences, Tokyo, Japan
700    1_
$a Okamoto, Nobuhiko $u Department of Medical Genetics, Osaka Women's and Children's Hospital, Osaka, Japan
700    1_
$a Firth, Helen $u Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, UK
700    1_
$a Metcalfe, Kay $u Manchester Centre for Genomic Medicine, Manchester, UK
700    1_
$a Moh, Anna $u Department of Genetics and Metabolism, Children's National Medical Center, Washington, DC, USA
700    1_
$a Chapman, Kimberly A $u Department of Genetics and Metabolism, Children's National Medical Center, Washington, DC, USA
700    1_
$a Aref-Eshghi, Erfan $u Molecular Genetics Laboratory, Victoria Hospital, London Health Sciences Centre, London, ON, Canada $u Department of Pathology and Laboratory Medicine, Western University, London, Canada
700    1_
$a Kerkhof, Jennifer $u Molecular Genetics Laboratory, Victoria Hospital, London Health Sciences Centre, London, ON, Canada
700    1_
$a Torella, Annalaura $u Telethon Institute of Genetics and Medicine, Pozzuoli, Italy $u Department of Precision Medicine, University of Campania Luigi Vanvitelli, Naples, Italy
700    1_
$a Nigro, Vincenzo $u Telethon Institute of Genetics and Medicine, Pozzuoli, Italy $u Department of Precision Medicine, University of Campania Luigi Vanvitelli, Naples, Italy
700    1_
$a Perrin, Laurence $u Department of Genetics, Robert Debré Hospital, AP-HP, Paris, France
700    1_
$a Piard, Juliette $u Centre de génétique humaine, Université de Franche-Comté, Besançon, France
700    1_
$a Le Guyader, Gwenaël $u Department of Medical Genetics, Poitiers University Hospital, Poitiers, France
700    1_
$a Jouan, Thibaud $u Inserm UMR 1231 GAD, Genetics of Developmental disorders, Université de Bourgogne-Franche Comté, FHU TRANSLAD, Dijon, France
700    1_
$a Thauvin-Robinet, Christel $u Inserm UMR 1231 GAD, Genetics of Developmental disorders, Université de Bourgogne-Franche Comté, FHU TRANSLAD, Dijon, France $u Centre de Référence Déficiences Intellectuelles de Causes Rares, CHU Dijon, Dijon, France $u UF Innovation en diagnostic génomique des maladies rares, CHU Dijon, Dijon, France
700    1_
$a Duffourd, Yannis $u Inserm UMR 1231 GAD, Genetics of Developmental disorders, Université de Bourgogne-Franche Comté, FHU TRANSLAD, Dijon, France
700    1_
$a George-Abraham, Jaya K $u Dell Children's Medical Group, Austin, TX, USA $u Department of Pediatrics, The University of Texas at Austin Dell Medical School, Austin, TX, USA
700    1_
$a Buchanan, Catherine A $u Dell Children's Medical Group, Austin, TX, USA
700    1_
$a Williams, Denise $u Birmingham Women's NHS Foundation Trust, Birmingham, UK
700    1_
$a Kini, Usha $u Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
700    1_
$a Wilson, Kate $u Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
700    1_
$a Sousa, Sérgio B $u Medical Genetics Unit, Hospital Pediátrico, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal $u University Clinic of Genetics, Faculty of Medicine, Universidade de Coimbra, Coimbra, Portugal
700    1_
$a Hennekam, Raoul C M $u Department of Pediatrics and Translational Genetics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
700    1_
$a Sadikovic, Bekim $u Molecular Genetics Laboratory, Victoria Hospital, London Health Sciences Centre, London, ON, Canada $u Department of Pathology and Laboratory Medicine, Western University, London, Canada
700    1_
$a Thevenon, Julien $u Department of Genetics and Reproduction, Centre Hospitalo-Universitaire Grenoble-Alpes, Grenoble, France
700    1_
$a Govin, Jérôme $u Inserm U1209, CNRS UMR 5309, Univ. Grenoble Alpes, Institute for Advanced Biosciences, Grenoble, France. Jerome.Govin@univ-grenoble-alpes.fr
700    1_
$a Vitobello, Antonio $u Inserm UMR 1231 GAD, Genetics of Developmental disorders, Université de Bourgogne-Franche Comté, FHU TRANSLAD, Dijon, France. Antonio.Vitobello@u-bourgogne.fr $u UF Innovation en diagnostic génomique des maladies rares, CHU Dijon, Dijon, France. Antonio.Vitobello@u-bourgogne.fr
700    1_
$a Brunetti-Pierri, Nicola $u Department of Translational Medicine, Federico II University, Naples, Italy. brunetti@tigem.it $u Telethon Institute of Genetics and Medicine, Pozzuoli, Italy. brunetti@tigem.it
710    2_
$a Telethon Undiagnosed Diseases Program
773    0_
$w MED00186213 $t Genetics in medicine : official journal of the American College of Medical Genetics $x 1530-0366 $g Roč. 22, č. 11 (2020), s. 1838-1850
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32694869 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830101507 $b ABA008
999    __
$a ok $b bmc $g 1690652 $s 1140336
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 22 $c 11 $d 1838-1850 $e 20200722 $i 1530-0366 $m Genetics in medicine $n Genet Med $x MED00186213
GRA    __
$a GSP15001 $p Telethon $2 Italy
GRA    __
$a 209568/Z/17/Z $p Wellcome Trust $2 United Kingdom
GRA    __
$p Department of Health $2 United Kingdom
GRA    __
$a NV17-29423A $p MZ0
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...